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BACKGROUND Meningiomas are the most commonly encountered nonglial primary intracranial tumors. The authors report on the usefulness
of intraoperative magnetic resonance imaging (iMRI) during microsurgical resection of meningiomas located close to eloquent areas or dural
sinuses and on the feasibility of further radiation therapy.
OBSERVATIONS Six patients benefited from this approach. Themean follow-up period after surgery was 3.3 (median 3.2, range 2.1–4.6) years. Five
patients had no postoperative neurological deficit, of whom twowith preoperativemotor deficit completely recovered. One patient with preoperative left
inferior limb deficit partially recovered. The mean interval between surgery and radiation therapy was 15.8 (median 16.9, range 1.4–40.5) months.
Additional radiation therapy was required in five cases after surgery. The mean preoperative tumor volume was 38.7 (median 27.5, range 8.6–75.6)
mL. The mean postoperative tumor volume was 1.2 (median 0.8, range 0–4.3) mL. At the last follow-up, all tumors were controlled.
LESSONS The use of iMRI was particularly helpful to (1) decide on additional tumor resection according to iMRI findings during the surgical
procedure; (2) evaluate the residual tumor volume at the end of the surgery; and (3) judge the need for further radiation and, in particular, the feasibility
of single-fraction radiosurgery.
https://thejns.org/doi/abs/10.3171/CASE20149
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Meningiomas are themost commonly encountered nonglial primary
intracranial tumors, with an incidence of approximately 20% of all
intracranial tumors.1 They are more frequent in adults during the fourth
through sixth decades of life.2,3 The clinical presentation is variable,
unspecific, and depends on tumor anatomical location.1 Magnetic
resonance imaging (MRI) is currently considered the imaging tech-
nique of choice and allows assessment of potential mass effect,
vascular supply, or degree of the peritumoral edema, as well as ac-
curate localization of meningioma.4 Some authors have suggested a
role for intraoperative MRI (iMRI) in the context of tailored patient
management.5
First-line therapy includes “wait-and-scan” observation, micro-
surgical resection,6 or radiosurgery.7 For patients who are considered
surgical candidates (those with surgically accessible lesions), the
goal is complete/gross-total microsurgical resection according to the
Simpson grade, as this is the most important factor influencing
recurrence.8,9 The use of radiation therapy and, particularly, stereo-
tactic radiosurgery (SRS) can be considered as an upfront therapeutic
approach following partial resection or for atypical or malignant
meningiomas.7,10,11 In such instances, iMRI could help to determine the
extent of resection (EOR). Moreover, and whenever necessary, it also
allows evaluation of the new anatomical relationships with surrounding
anatomical structures, both vascular and functional. Thus, it may help in
decision-making with regard to the feasibility of combined approaches
with adjuvant SRS12,13 or fractionated radiotherapy (FRT) while de-
creasingmortality andmorbidity and preserving quality of life. The well-
known risks for adjuvant SRS are mainly related to the volume of the
lesion, the anatomical location, and the delivered dose.14
ABBREVIATIONS ARE = adverse radiation event; DTI = diffusion tensor imaging; EOR = extent of resection; fMRI = functional MRI; FRT = fractionated radiotherapy; GK =
Gamma Knife; iMRI = intraoperative MRI; MRI = magnetic resonance imaging; OR = operating room; SRS = stereotactic radiosurgery; WHO = World Health Organization.
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Complete microsurgical resection can be curative.3,8,9,15 In an attempt
to enhance anatomical location and resection, it has been previously
proposed to introduce iMRI,16,17 particularly for patients harboring intra-
cranial meningiomas in proximity to eloquent areas (e.g., motor related,
rolandic, speech related, or Broca)18 or those invadingmajor dural venous
sinuses.19,20 Such anatomical locations can be at risk for higher post-
operative deficits but also for harboring tumor remnants after surgery,
potentially leading to further recurrences.
Here, we present the combined use of iMRI and microsurgical
resection, followed or not by radiation therapy, depending on tailored
patientmanagement. The primary research question waswhether iMRI
could help with deciding on additional tumor resection and evaluating
residual tumor at the end of surgery, as well as the feasibility of further
radiation and, in particular, single-fraction SRS.
Study Description
Patient Population
Starting November 2016 through November 2020, six patients
benefited from iMRI and microsurgical resection. There was no patient
lost to follow-up. All patients were operated on by the senior neuro-
surgeon (J-P.L.). Although we had planned to perform iMRI in the
dedicated operating room (OR) on one patient, the imaging was
unnecessary because complete microsurgical resection had been
successful and there was no doubt regarding any potential tumor
remnant.
The inclusion criteria were as follows: patients with intracranial me-
ningioma suspected on preoperative MRI, independent of age, with mi-
crosurgical resection in the iMRI setting andOR. Exclusion criteria were an
inability to provide informed consent and the absence of an iMRI
procedure.
Basic demographic data can be seen in Table 1. The female-to-male
ratio was 4:2. The tumor location was as follows: convexity, in proximity to
the rolandic area (n = 4); convexity, in proximity to the Broca area (n = 1);
and parasagittal with invasion of the superior sagittal sinus (n = 1). The
mean age at the time of surgery was 58.4 (median 60.6, range 46.9–69.7)
years. The context of preoperative discovery was paresthesias (n = 1),
inferior limb deficit (n = 2), hemiparesis (n = 1), or incidental (n = 2).
Preoperative MRI
Preoperative MRI included, besides standard assessment, diffu-
sion tractography (diffusion tensor imaging [DTI]) and tasked-based
functional MRI (fMRI), whenever necessary, as depending on the
anatomical location.
Intraoperative Imaging Using iMRI
Patients benefitted from intraoperative 1.5 tesla MRI (General Electric).
WeusedanMRI-compatible headholder to position the patient. The imaging
sequences for neuronavigation were three-dimensional turbo-spin echo T1
with and without gadolinium injection. Beforemoving patients into theMRI, a
checklist was systematically completed to ensure the absence of metallic
material on the surgical site that could potentially interfere with the magnetic
field. The neuronavgation data update procedure was performed using the
automatic coregistration provided by Brainlab (BrainlabAG). The quality and
accuracy of the coregistration were double-checked by an imaging engineer
and board-certified neurosurgeon.21 We always discussed the MRI with our
neuroradiologist so as to evaluate the EOR and other surgery-related as-
pects. The surgicalmicroscope (OPMIPentero; Zeiss) was connected to the
imaging network and could be used as neuronavigation.
Volumetric Measurements
Volumetricmeasurementswereperformedwith theLeksellGammaPlan
software (Elekta Instruments AB), using both pre- and postoperative T1-
weighted gadolinium-injected MR sequences (1-mm slices). The module
automatic segmentation using a standard contrast amount was initially used.
The first volume draft was further refined using manual drawing.
Basic Pre- and Postoperative Volumetric Data and
Histopathological Diagnosis
Basic volumetric data can be seen in Table 2. The mean pre-
operative tumor volume was 38.7 (median 27.5, range 8.6–75.5) mL.
TABLE 1. Basic demographic data
Case



































18.3 No deficit 3.4; 1.9 I
3 F Lt Convexity
(language area)
Incidental 46.9 47 (GK) 1.4 No deficit 4.6; 4.5 I
4 F Rt Convexity
(rolandic area)
Lt hemiparesis 58.1 58.3
(RT)
1.9 No deficit (complete
recovery)
2.1; 2 II




69.7 N/A N/A No deficit (complete
recovery)
3; N/A I






16.9 Partial recovery 2.7; 1.3 II
FU = follow-up; N/A = not applicable; RT = radiotherapy; SSS = superior sagittal sinus.
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The mean postoperative tumor volume was 1.2 (median 0.8, range
0–4.3) mL. The World Health Organization (WHO) classification was
grade I for four cases and grade II for two cases.
Radiation Therapy Details and Follow-Up Course
Postoperative radiation after surgery was performed in five
cases. Of these, three involved single-fraction Gamma Knife (GK)
4C and later ICON models (Elekta Instruments AB) for WHO grade
I, and two involved FRT for WHO grade II. One WHO grade I
meningioma did not benefit from adjuvant radiation therapy due to a
stable minimal residual tumor volume. For single-fraction SRS, the
marginal dose prescribed was 14 Gy (n = 2) or 15 Gy (n = 1) at the 50%
isodose line. For FRT, one patient received 54 Gy while the other had
36 Gy in 9 fractions. The mean tumor volume at the time of radiation was
2.4 (median 1.6, range 0.2–5.2) mL. The mean volume at the last follow-
up was 1.8 (median 1.6, range 0.1–4.3) mL.
Follow-Up Period After Surgery
Themean follow-up period after surgery was 3.3 (median 3.2, range
2.1–4.6) years.
Neurological Evaluation After Surgery
Five patients had no postoperative neurological deficit, of whom two
with preoperative motor deficit completely recovered (cases 5 and 6).
One patient with preoperative left inferior limb deficit partially recovered
(case 6, Table 1).
Interval Between Surgery and Radiation Therapy
The mean interval between surgery and radiation therapy was 15.8
(median 16.9, range 1.4–40.5) months.
Follow-Up Period After Radiation
The mean follow-up period after radiation was 2.1 (median 1.9,
range 1–4.5) years.
Tumor Control at Last Follow-Up
At the last follow-up, all tumors were controlled.
Illustrative Case 3 Benefiting From iMRI and
Combined Approach
A 47-year-old female presented to our outpatient clinic with an
incidentally discovered left convexity meningioma close to the lan-
guage areas (left Broca, Fig. 1A). In this ambidextrous patient, pre-
operative fMRI revealed bilateral language activation with left
dominance (Fig. 1A). The preoperative tumor volume was 35.7 mL
(Fig. 1B).
Gross-total microsurgical resection (Fig. 1C) was performed, with
further iMRI during surgery (Fig. 2A). The former confirmed a small
residual tumor compatible with adjuvant GK surgery, which was then
performed on a volume of 0.7 mL with a dose of 14 Gy at the 50%
isodose line (Fig. 2B).
At the last follow-up 4 years after GK surgery, the tumor decreased
in size, passing from 0.7 mL to 0.1 mL. The patient was neurologically
intact (Fig. 2C).
Illustrative Case 2 Benefiting From iMRI and
Combined Approach
A45-year-old female presentedwith a left parasagittal meningioma,
with invasion of the superior sagittal sinus (Fig. 3A, volume = 19.4 mL).
A gross-total resection was later performed, with iMRI showingminimal
residual tumor (Fig. 3B). MRI 6 months after surgery and another 16 months
later displayed a volumetric increase (Fig. 3C); the patient underwent GK
surgery with a dose of 15 Gy at the 50% isodose line on a volume of 1.6 mL
(Fig. 4A). Two years after GK surgery, follow-up MRI showed volumetric
decrease (Fig. 4B, volume = 1.4 mL).
Illustrative CaseWith Initial Decision but No Further iMRI Need
A 37-year-old female presented with a left frontal anterior para-
sagittal meningioma incidentally discovered (Fig. 5A andB) close to the
motor strip (Fig. 5A left, DTI showing the pyramidal tract in blue) and
the language areas (Fig. 5A right, fMRI). iMRI was initially scheduled
during resection. However, there was a clear cleavage plane and no
intraoperative residual tumor. The intraoperative macroscopic as-
pect (Fig. 5C) suggested total resection. We did not perform iMRI as
it was not necessary.
Discussion
Observations
The present study evaluates the benefit and feasibility of the
combined use of microsurgical resection and iMRI for meningiomas
close to eloquent areas or major dural sinuses. Of note, our neuro-
surgical setting benefits from both an iMRI and an SRS unit (GK, Elekta
Instruments AB). First, we consider the presurgical detailed neuro-
imaging evaluation as mandatory. Several factors can suggest the
feasibility of complete microsurgical resection, depending on whether a
potential cleavage plane is present. The three key factors are a T2 cleft
sign,22 meningioma volume23 on preoperative MRI, and significant
corticopial vascularization on preoperative digital subtraction angi-
ography.24 Moreover, larger meningiomas would tend to potentially
infiltrate the arachnoidal plane more frequently than the smaller ones,
therefore causingedemaand resulting in the lackofa cleavageplane.18We







Late Postop Vol in mL
(yrs since surgery for the
growing residual tumor)
WHO
Grade GK/RT Radiation Dose Vol at Radiation (mL)
Vol at Last FU (mL);
Yrs Since Radiation
1 17.6 1.4 3.1 (3) I GK 14 Gy at 50% 5.2 2.8; 1
2 19.4 1.5 1.5 I GK 15 Gy at 50% 1.6 1.4; 1.9
3 35.7 N/A 0.7 I GK 14 Gy at 50% 0.7 0.1; 4.5
4 75.6 0.2 0.2 II RT 54 Gy 0.2 0.2; 2
5 8.6 0.01 0.01 I N/A N/A N/A N/A
6 75.5 4.3 4.3 II RT 36 Gy in 9 fractions 4.3 4.3; 1
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complete the neuroimaging assessment with DTI or fMRI whenever
necessary, depending on the exact anatomical location. Here, we discuss
the combined use of iMRI and microsurgical resection, followed or not by
radiation therapy, depending on tailored patient management. iMRIwas, in
our experience, particularly useful to evaluate the volume residue (if any) to
be able to continue microsurgical resection while using up-to-date images
or to evaluate a particular anatomical relationship (mainly vascular). In our
opinion, such aspects could enhance the preservation of neurological
function and thus quality of life.
Convexity Meningiomas Located Within the Rolandic Area
Convexity meningiomas located within the rolandic areas pose
specific microsurgical issues. As opposed to classic convexity me-
ningiomas, which only require a rather low-risk procedure,25 they may
engender postoperative motor deficits with a risk ranging between
7.1% and 24.7%26 of cases.18 Moreover, such risks become higher
when a clear arachnoidal cleavage plane with the motor pathway (e.g.,
corticospinal tract and the primary motor cortex) is not directly
identifiable. Thus, combined strategies using a wide range of tech-
niques have been reported, including preoperative DTI,18 navigated
transcranial magnetic stimulation,27 or intraoperative neurophysio-
logical mapping, with the latter rarely discussed for rolandic menin-
giomas andwith questionable usefulness.26 In fact, all these techniques
have their pitfalls and challenges. We consider the use of iMRI par-
ticularly useful in this anatomical location, especially for evaluating the
anatomical relationship with the primary motor cortex but also for
volumetric issues. Moreover, iMRI particularly helps to decide on
additional tumor resection according to its findings during the surgical
procedure, evaluate the residual tumor volume at the end of the
surgery, and judge the need for further radiation and, in particular, the
feasibility of single-fraction radiosurgery.
Meningiomas Involving Major Dural Sinuses
Concerning the surgical management of meningiomas involving
major dural sinuses, the great surgical dilemma is whether the surgeon
should leave a residual tumor fragment or perform complete microsurgical
FIG. 1. Illustration of a combined approach and using iMRI (case 3). A: Convexity meningioma close to the
pars triangularis and opercularis, found at the posterosuperior pole of the tumor. B: MRI before surgery,
reconstructed in the coronal, axial, and sagittal planes (tumor volume = 35.7 mL). C: Intraoperative
macroscopic aspect at the beginning of the surgery (left, center) and at the end of the surgery (right).
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resection, with a risk for the venous circulation.20 Such a residualmeningioma
would result in higher tumor recurrence.9 Several approaches have been
discussed over the years, including resecting the tumor outside the sinus wall
and coagulating the remnant with or without en bloc removal of the residual
fragment if the sinus is already occluded.28 However, complete removal and
eventual venous infarcts could place patients at risk for major postoperative
neurological deficits, impairing quality of life20,29 or even causing death, ac-
cording to some series,20 if performing aggressive resection. In a recent
paper20 whose authors also performed a systematic review of meningiomas
involving major dural sinuses and reconstruction procedures, the recurrence
rate rangedbetween4%and23.9%afteramedian follow-upofbetween5and
13 years; the overall mortality was between 0%and 12.3%.20 These risks are
also related to sacrificing cortical bridging veins with further venous en-
gorgement and decrease in vascular flow, with venous stasis and eventual
thrombosis. On the other hand, subtotal resection without radiation poses the
challenge of later tumor recurrence.30 Thus, there is a need to develop new
treatment paradigms, aiming at preserving neurological function. Among
those, SRShas been suggested to prevent tumor recurrence or regrowth.31,32
Combined Approaches With Planned Subtotal Resection
Followed by Radiosurgery
During the past years, combined approaches with postoperative
adjuvant radiosurgery on the postoperative residual tumors have been
proposed,33 aiming at conserving neurological function.34–36 Such
approaches depend mainly on the residual tumor volume to safely
perform SRS as an adjuvant therapy.37 Long-term tumor control after
SRS also depends on histology, being as high as 93%–95% for WHO
grade I, 50%–60% for WHO grade II, and decreasing to 10%–17% for
WHO grade III.38 Concerning WHO grade I meningiomas, 40%–80%
will shrink by approximately 25%–40% of volume after SRS during the
FIG. 2. Illustration of a combined approach and using iMRI (case 3). A: Convexity meningioma close to the
pars triangularis and opercularis on iMRI, showingminimal residual tumor, reconstructed in the coronal, axial,
and sagittal planes.B:MRI at the time of GK surgery, which was 2months after surgery, reconstructed in the
coronal, axial, and sagittal planes (tumor volume = 0.7 mL). C:MRI 4 years after GK surgery, reconstructed
in the coronal, axial, and sagittal planes (tumor volume = 0.1 mL). Arrows point out the residual meningioma
after surgery at the time of GK (B) and at last follow-up (C).
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FIG. 3. Illustration of a combined approach and using iMRI (case 2).A:PreoperativeMRI reconstructed in the
coronal, axial, and sagittal planes and showing a left parasagittal meningioma invading the superior sagittal
sinus (lesion volume 19.4 mL). B: iMRI reconstructed in the coronal, axial, and sagittal planes (lesion
volume = 1.4 mL). C: MRI 6 months after surgery (arrows show the residual meningioma).
FIG. 4. Illustration of a combined approach and using iMRI (case 2). A: MRI at the time of GK surgery, with
superimposed dosimetry in yellow, 16months after surgery (lesion volume = 1.6mL).B:MRI 2 years after GK
surgery, with superimposed dosimetry in yellow (lesion volume = 1.4 mL).
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follow-up course. In summary, most of the published series report
excellent results on tumor control for WHO grade I meningiomas,
ranging between 86.7%39 and 100%.40,41 An important aspect, illus-
trated by Zachenhofer et al.,42 is that patients could be “late re-
sponders” with a tumor starting to shrink beyond 4 years after SRS.
Radiosurgery has also a risk of symptomatic imaging-demonstrated
changes, which are frequently transient.36 The risk of such adverse ra-
diation events (AREs) after SRS is mostly related to symptomatic edema
or damage to the cranial nerves. In a recent meta-analysis,43 which in-
cluded 4229 patients, the overall relative frequency of AREs was 8.1%
(range 5.2%–11.5%). In the vast majority of cases, the morbidity was
transient and rarely disabling. Permanent complications have been re-
ported in only to 2.5% to 9% of cases. The optimal SRS marginal pre-
scribeddose is still amatter of debate in the current literature.Usually, dose
prescription depends on tumor volume, surrounding risk structures (such
as theoptic nerve, cochlea), andhistology (if availableat the timeofSRS). It
is currently commonly considered that marginal doses below 12 Gy are
associated with further tumor growth.44 Moreover, doses of more than
15 Gy do not enhance tumor control for WHO grade I meningiomas.45
Limitations
Our case series has several inherent limitations. The first is the low
number of cases inwhich suchanapproachwasconsidered. Thesecond is
related to the timing of iMRI use during surgery, which we leave until the
moment when we consider resection as reasonably complete without
excessive surgical risk. However, such evaluation remains very subjective,
and it may be difficult to visually assess the residual volume during surgery
using visual inspection only and, furthermore, to decide the exact timing of
iMRI. The third is the timing of radiosurgery or FRT. In the present series,
only one case did not benefit from adjuvant treatment given a minimal and
stable postoperative residue.
Lessons
Combined approaches with subtotal/gross-total resection followed
by SRS are appealing in order to preserve a patient’s neurological
function and thus their quality of life. Such a treatment paradigm should
be based on tailored management. The use of iMRI was particularly
helpful to (1) decide on additional tumor resection according to iMRI
findings during the surgical procedure, (2) evaluate the residual tumor
volume at the end of the surgery, and (3) judge the need for further
radiation and, in particular, the feasibility of single-fraction radiosurgery.
However, iMRI should be used carefully and not dogmatically as it is a
powerful, yet one of many, neurosurgical tools.
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